Results for prevoir revision translation from Dutch to Swedish

revision of art.
revision of art.

revision oktober 1998
revision october 1998

emea/ cvmp/ 422/ 99 – revision
emea/ cvmp/ 422/ 99 – revision

davidoff bij het tot .revision" verworpen.
med hänsyn till artikel 5.2 i direktivet, men att tolkningen som görs vid denna prövning i tillämpliga delar även kommer att kunna tillämpas på artikel 4.4 a i direktivet.

referentienummer emea/cvmp/145/97-revision
referensnummer emea/ cvmp/ 145/ 97- revision

maierhofer heeft vervolgens „revision" ingesteld bij het bundesfinanzhof.
det är i detta avseende av betydelse att konstruktionerna inte är enkla att montera ned eller flytta.

ziekte zoals gedefinieerd in de international classification of diseases, 10th revision.
sjukdom enligt definitionen i international classification of diseases, tionde reviderade upplagan.

e-mail: comp-revision-1617-93@cec.eu.int
e-post: comp-revision-1617-93@cec.eu.int

declaration of storage conditions for veterinary medicinal products and active substances – revision
declaration of storage conditions for veterinary medicinal products and active substances – revision

clinical investigation of medicinal products for the treatment of cardiac failure (revision)
clinical investigation of medicinal

deze revisie wordt gebruikt als het tweede item van een diff-operatie.to view revision a
den här versionen används som det andra objektet vid en jämförelse. to view revision a

kpmg deutsche treuhandgesellschaft ag en pwc deutsche revision ag worden aanvaard als externe accountants van de deutsche bundesbank;
kpmg deutsche treuhandgesellschaft ag och pwc deutsche revision ag godkänns härmed som externa revisorer för deutsche bundesbank.

clinical investigation of medicinal products for the treatment of peripheral arterial occlusive disease (revision)
emea/ mb/ 040/ 98 © emea 1999 fjärde allmänna rapporten om verksamheten vid emea 1998 products for the treatment of peripheral arterial occlusive disease (revision)

titel document revision of note for guidance on carcinogenic potential (3bs7a, volume 3b, 1998, p.
dokumenttitel revision of note for guidance on carcinogenic potential (3bs7a, volume 3b, 1998, p.

comments and proposals for revision of the notice to applicants volume 2b parts ic1 and ii, including proposal for tabular formats specific to herbal medicinal products
comments and proposals for revision of the notice to applicants volume 2b parts ic1 and ii, including proposal for tabular formats specific to herbal medicinal products

cvmp algemeen referentienummer emea/ cvmp/ 695/ 01 emea/ cvmp/ 328/ 98 – revision 2
cvmp generellt referensnummer emea/ cvmp/ 695/ 01

stability testing: stability testing of existing active substances and related finished products – revision european drug master file – revision
stability testing: stability testing of existing active substances and related finished products – revision

need for post-marketing data contribution to cpmp points to consider document on xenogeneic cell therapy proposals for revision to standard operating procedure on urgent safety restrictions for medicinal products authorised through the mutual recognition procedure
need for post- marketing data contribution to cpmp points to consider document on xenogeneic cell therapy proposals for revision to standard operating procedure on urgent safety restrictions for medicinal products authorised through the mutual recognition procedure

diensten op het gebied van hoger secundair onderwijs, op niveau 3 van de isced-2011 (international standard classification of education, 2011 revision).
tjänster som rör gymnasieutbildning på isced-2011 (international standard classification of education, 2011 revision) nivå 3.

concept paper on the revision of the cpmp/bwp note for guidance (cpmp/bwp/214/96) on harmonisation of requirements for influenza vaccines
concept paper on the revision of the cpmp/ bwp note for guidance (cpmp/ bwp/ 214/ 96) on harmonisation of requirements for influenza vaccines